Cargando…
Differential Spatial Gene and Protein Expression Associated with Recurrence Following Chemoradiation for Localized Anal Squamous Cell Cancer
SIMPLE SUMMARY: While anti-PD1 antibodies have demonstrated efficacy in some patients with metastatic anal cancer, these agents have no proven benefit for those with localized disease treated with chemoradiation. Difficulty procuring fresh tumor tissue required for RNA and protein expression analysi...
Autores principales: | Hernandez, Sharia, Das, Prajnan, Holliday, Emma B., Shen, Li, Lu, Wei, Johnson, Benny, Messick, Craig A., Taniguchi, Cullen M., Skibber, John, Ludmir, Ethan B., You, Y. Nancy, Smith, Grace Li, Bednarski, Brian, Kostousov, Larisa, Koay, Eugene J., Minsky, Bruce D., Tillman, Matthew, Portier, Shaelynn, Eng, Cathy, Koong, Albert C., Chang, George J., Foo, Wai Chin, Wang, Jing, Soto, Luisa Solis, Morris, Van K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046657/ https://www.ncbi.nlm.nih.gov/pubmed/36980587 http://dx.doi.org/10.3390/cancers15061701 |
Ejemplares similares
-
Definitive Intensity-Modulated Chemoradiation for Anal Squamous Cell Carcinoma: Outcomes and Toxicity of 428 Patients Treated at a Single Institution
por: Holliday, Emma B, et al.
Publicado: (2022) -
Patient-Reported Outcomes After Chemoradiation in Patients With Anal Cancer: A Qualitative Analysis
por: Corrigan, Kelsey L., et al.
Publicado: (2022) -
CEA as a blood-based biomarker in anal cancer
por: Hester, Robert, et al.
Publicado: (2021) -
Anal cancer treatment regimen considerations for the COVID-19 era: In regard to Tchelebi et al
por: Noticewala, Sonal S., et al.
Publicado: (2020) -
Treatment of primary rectal adenocarcinoma after prior pelvic radiation: The role of hyperfractionated accelerated reirradiation
por: Jensen, Garrett, et al.
Publicado: (2018)